Overdiagnosis in the Age of Digital Cancer Screening
A partir d'une revue systématique de la littérature (24 études, plus de 16 millions examens de dépistage), cette méta-analyse évalue l'efficacité, du point de vue du taux de détection et de la réduction du taux de cancer de l'intervalle, de la mammographie numérique plein champ par rapport à la mammographie analogique
In 2000, the US FDA approved digital mammography technology. Studies suggested the new technology was equivalent to older film technology in detecting cancer. There was also limited evidence that digital imaging might be more specific, meaning that it would reduce the number of call backs for positive findings. Manyalso believedthat the newer “improved” digital technology might find more diseaseand lead to less interval cancers (cancers diagnosed between scheduled screening).
Journal of the National Cancer Institute , éditorial en libre accès, 2019